TransMedics Group Inc (TMDX)

Exchange
NASDAQ
Symbol
TMDX
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Country
USA

Stock price

At close: September 18, 2025

  • Open
    119.40
  • High
    122.05
  • Low
    114.91
  • Close
    121.10
  • Volume
    1,020,780

Financial ratios

Dec 31, 2024